Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513

Watchlist Manager
Chengdu Easton Biopharmaceuticals Co Ltd Logo
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
Watchlist
Price: 30.69 CNY 0.39% Market Closed
Market Cap: 5.4B CNY
Have any thoughts about
Chengdu Easton Biopharmaceuticals Co Ltd?
Write Note

Chengdu Easton Biopharmaceuticals Co Ltd
Net Change in Cash

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Chengdu Easton Biopharmaceuticals Co Ltd
Net Change in Cash Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Net Change in Cash CAGR 3Y CAGR 5Y CAGR 10Y
Chengdu Easton Biopharmaceuticals Co Ltd
SSE:688513
Net Change in Cash
-ÂĄ54.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Net Change in Cash
ÂĄ3.3B
CAGR 3-Years
N/A
CAGR 5-Years
37%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Net Change in Cash
ÂĄ6.1B
CAGR 3-Years
N/A
CAGR 5-Years
25%
CAGR 10-Years
N/A
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Net Change in Cash
ÂĄ4.4B
CAGR 3-Years
18%
CAGR 5-Years
N/A
CAGR 10-Years
13%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Net Change in Cash
ÂĄ359.1m
CAGR 3-Years
-67%
CAGR 5-Years
-44%
CAGR 10-Years
N/A
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Net Change in Cash
-ÂĄ609m
CAGR 3-Years
-45%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Chengdu Easton Biopharmaceuticals Co Ltd
Glance View

Market Cap
5.4B CNY
Industry
Pharmaceuticals

Chengdu Easton Bio Pharmaceuticals Co., Ltd. engages in the research and development, production, and sale of chemical raw materials and chemical drug preparations. The company is headquartered in Chengdu, Sichuan and currently employs 1,188 full-time employees. The company went IPO on 2020-09-02. The firm's main products are chemical generic drugs. Its products include nalmefene hydrochloride injection, caffeine citrate injection, ibuprofen injection, bisoprolol fumarate tablets, ubenimex, etc. Its products are used in the fields of anesthesia and analgesia, cardiovascular, anti-tumor, digestion and children's medicine. The firm operates its businesses within the China market and to overseas markets such as Russia, Switzerland, Tunisia, Germany, South Korea and Japan.

Intrinsic Value
50.98 CNY
Undervaluation 40%
Intrinsic Value
Price

See Also

What is Chengdu Easton Biopharmaceuticals Co Ltd's Net Change in Cash?
Net Change in Cash
-54.3m CNY

Based on the financial report for Dec 31, 2023, Chengdu Easton Biopharmaceuticals Co Ltd's Net Change in Cash amounts to -54.3m CNY.

What is Chengdu Easton Biopharmaceuticals Co Ltd's Net Change in Cash growth rate?
Net Change in Cash CAGR 1Y
75%

Over the last year, the Net Change in Cash growth was 75%.

Back to Top